Citation Impact
Citing Papers
Review article: the global emergence of Helicobacter pylori antibiotic resistance
2015
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Helicobacter pylori Primary Antibiotic Resistance in 2015 in Morocco: A Phenotypic and Genotypic Prospective and Multicenter Study
2016
Hallmarks of Cancer: The Next Generation
2011 Standout
Astrocytes: biology and pathology
2009 Standout
Angiogenesis in pre-malignant conditions
2009
DNA in a material world
2003 StandoutNature
Tumors are unique organs defined by abnormal signaling and context
2001
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Ulcerative Colitis
2011 Standout
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
DNA‐Coated AFM Cantilevers for the Investigation of Cell Adhesion and the Patterning of Live Cells
2008 StandoutNobel
Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique
2005
Tetracycline, metronidazole and amoxicillin‐metronidazole combinations in proton pump inhibitor‐based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection
2006
A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey
2011
Standard triple, bismuth pectin quadruple and sequential therapies forHelicobacter pylorieradication
2010
Resistance ofHelicobacter pylorito antibiotics from 2000 to 2009 in Shanghai
2010
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
2014
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
2016
Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer
2006
Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection
2016
A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
2014
Invasive and non‐invasive tests for Helicobacter pylori infection
2000
Protein—DNA recognition complexes: Conservation of structure and binding energy in the transition state
1997
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Hepatocellular carcinoma
2012 Standout
Meta‐analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first‐line therapies for Helicobacter pylori
2007
Artificial Molecular Clamp: A Novel Device for Synthetic Polymerases
2011
Purification, crystallization, and preliminary x-ray diffraction analysis of an M.HhaI-AdoMet complex
1992 StandoutNobel
Reprogramming Cellular Identity for Regenerative Medicine
2012
Cells on chips
2006 StandoutNature
Eradication of gastric cancer is now both possible and practical
2013
Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis
2015
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Accuracy of Monoclonal Stool Antigen Test for the Diagnosis ofH. pyloriInfection: A Systematic Review and Meta-Analysis
2006
High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates
2010
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
2011
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
1996
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
2015
Pouchitis: What Every Gastroenterologist Needs to Know
2013
Crystal structure of the Hhal DNA methyltransferase complexed with S-adenosyl-l-methionine
1993 StandoutNobel
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Central nervous system control of food intake
2000 StandoutNature
Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin‐Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin‐Resistant Strains
2012
Restriction enzymes and their isoschizomers
1990 StandoutNobel
Necrotizing Enterocolitis
2011 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
2013
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Pausing of the Restriction Endonuclease EcoRI during Linear Diffusion on DNA
1994
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
2011
Accuracy of GastroPanel for the diagnosis of atrophic gastritis
2014
Helicobacter pyloritherapy: Present and future
2012
Live and Heat-Killed Lactobacillus rhamnosus GG: Effects on Proinflammatory and Anti-Inflammatory Cytokines/Chemokines in Gastrostomy-Fed Infant Rats
2009
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
2013
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
EMT: 2016
2016 Standout
Ulcerative colitis
2016 Standout
Assessment of Sequential and Standard Triple Therapy in Treatment of Helicobacter pylori Infection in Children Dependent on Bacteria Sensitivity to Antibiotics
2016
Time trends of primary antibiotic resistance ofHelicobacter pyloriisolates in Southern Croatia
2012
Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany
2009
Structure of the Human Telomerase RNA Pseudoknot Reveals Conserved Tertiary Interactions Essential for Function
2005
Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment forHelicobacter pyloriinfection
2015
Blood, urine, stool, breath, money, and Helicobacter pylori
2001
Gastric cancer
2020 Standout
Pouchitis and Pouch Dysfunction
2009
Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients Compared with Age-Sex Matched Controls
2013
Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
2014
Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance
2013
STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
2008
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
2012
Cloning theBamHI restriction modification system
1989
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
2000
Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori
2012
Neuro-Immune Interactions at Barrier Surfaces
2016
The DNA binding affinity ofHhalmethylase is increased by a single amino acid substitution in the catalytic center
1993 StandoutNobel
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Specificity of restriction endonucleases and DNA modification methyltransferases — a review (edition 3)
1990
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Cloning and characterization of theHpallmethylase gene
1990 StandoutNobel
Pretreatment Antimicrobial Susceptibility-Guided Vs. Clarithromycin-Based Triple Therapy for Helicobacter pylori Eradication in a Region With High Rates of Multiple Drug Resistance
2014
Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: a Systematic Review
2004
Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
2013
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
2009
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use
2015
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
2012
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Genomics and Signaling Pathways in Hepatocellular Carcinoma
2007
Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication
2008
The real-time polymerase chain reaction
2006
Standard triple and sequential therapies for Helicobacter pylori eradication: An update
2012
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer
2010
Update on therapeutic options for Helicobacter pylori-related diseases
2005
Helicobacter pylori and gastrointestinal tract adenocarcinomas
2002
Value of gastrin-17 in detecting antral atrophy
2011
Modeling Development and Disease with Organoids
2016 Standout
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Ten‐day sequential versus triple therapy for H elicobacter pylori eradication: A prospective, open‐label, randomized trial
2012
Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-
2010
Kinetic Characterization of Linear Diffusion of the Restriction Endonuclease EcoRV on DNA
1998
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
2014
Hybridization and Enzymatic Extension of Au Nanoparticle-Bound Oligonucleotides
2002
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Comparison of Hybrid and Sequential Therapies for H elicobacter pylori Eradication in I ran: A Prospective Randomized Trial
2012
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
Specificity of restriction endonucleases and methylases — a review (edition 2)
1986
High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland
2016
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Antibiotic resistance of Helicobacter pylori in Mashhad, Iran.
2013
Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight
1999
Prevalence of Primary and Secondary Antimicrobial Resistance of H elicobacter pylori in K orea from 2003 through 2012
2012
The sequence specificity domain of cytosine-C5 methylases
1991 StandoutNobel
Evaluation of Commercially AvailableHelicobacter pyloriSerology Kits: a Review
1998
Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for <i>Helicobacter pylori</i> Eradication
2015
Piezoelectric Nanogenerators Based on Zinc Oxide Nanowire Arrays
2006 StandoutScience
Primary antibiotic resistance ofHelicobacter pyloristrains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
2015
The Kinetic Mechanism of EcoRI Endonuclease
1999 StandoutNobel
Clinical Evaluation of a Ten‐Day Regimen with E someprazole, M etronidazole, A moxicillin, and C larithromycin for the Eradication of H elicobacter pylori in a High Clarithromycin Resistance Area
2013
Artificial Molecular Machines
2015 Standout
Modified Sequential Therapy Regimen versus Conventional Triple Therapy forHelicobacter pyloriEradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study
2012
Sitafloxacin Activity against Helicobacter pylori Isolates, Including Those with gyrA Mutations
2009
Evolution of H elicobacter pylori susceptibility to antibiotics during a 10‐year period in L ithuania
2012
Functional analysis of the pseudoknot structure in human telomerase RNA
2005 StandoutNobel
Helicobacter pylori Eradication Rates in Children Upon Susceptibility Testing Based on Noninvasive Stool Polymerase Chain Reaction Versus Gastric Tissue Culture
2011
Relative Quantification of Proteins in Human Cerebrospinal Fluids by MS/MS Using 6-Plex Isobaric Tags
2008
Antimicrobial Susceptibility‐Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance
2015
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Linear diffusion of the restriction endonuclease EcoRV on DNA is essential for the in vivo function of the enzyme.
1996
Works of Gerardo Nardone being referenced
Investigation of intestine function during acute viral hepatitis using combined sugar oral loads.
1987
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy
2005
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
2010
Activation of Fetal Promoters of Insulinlike Growth Factors Ii Gene in Hepatitis C Virus-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma
1996
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors
2011
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression
2006
Molecular basis of gastric carcinogenesis
2003
Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments
2002
Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial‐derived S100B protein
2009
<i>Helicobacter pylori</i> and Epigenetic Mechanisms Underlying Gastric Carcinogenesis
2007
Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
2012
Helicobacter pylori and molecular events in precancerous gastric lesions
2004
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G to Helicobacter pylori
2000
Helicobacter pylori and gastric malignancies
2003
Twice-Daily Standard Dose of Omeprazole Achieves the Necessary Level of Acid Inhibition for Helicobacter pylori Eradication. A Randomized Controlled Trial Using Standard and Double Doses of Omeprazole in Triple Therapy
2005
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection
2012
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates
2008
Enteric Glial-Derived S100B Protein Stimulates Nitric Oxide Production in Celiac Disease
2007
Effect of Helicobacter pyloriinfection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
1999
Vascular endothelial growth factor and neo‐angiogenesis in H. pylori gastritis in humans
2005
Risk factors for cancer development in Helicobacter pylori gastritis
2000
Chemoprevention of Gastric Cancer: Role of COX-2 Inhibitors and Other Agents
2004
Vascular Endothelial Growth Factor and Cyclooxygenase-2 are Overexpressed in Ileal Pouch-Anal Anastomosis
2006
In Vitro–Deranged Intestinal Immune Response to Gliadin in Type 1 Diabetes
2004
Detection of Telomerase Activity Utilizing Energy Transfer Primers: Comparison with Gel- and ELISA-Based Detection
1999
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori
2003
Differences in the kinetic properties of BamHI endonuclease and methylase with linear DNA substrates.
1986
Sequence-specific BamHI methylase. Purification and characterization.
1984
In Vivo and In Vitro Studies of Cytosolic Phospholipase A2Expression inHelicobacter pyloriInfection
2001
Gastric Cancer—Epidemiologic and Clinical Aspects
2014
The integrity of the cholecystokinin receptor gene in gallbladder disease and obesity*1
1995
Rapid and Sensitive Closed-Tube Quantification of Human Interferon-γ mRNA by Reverse Transcription-PCR Utilizing Energy-Transfer Labeled Primers
2000
The integrity of the cholecystokinin receptor gene in gallbladder disease and obesity
1995
Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection.
1997
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of
2003
Risk factors in gastric cancer.
2010
Treatment of chronic hepatitis C with recombinant interferon alfa.
1992